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ABSTRACT
We aimed to assess the prevalence, correlates of psychoactive substance use including 
misuse of prescription medications and its associated harm among a group of elderly 
patients attending three primary care facilities in Benin-city, Edo state, Nigeria. The 
WHO ASSIST was administered to assess for psychoactive substance use and level of risk 
of some elderly participants. Lifetime prevalence and current prevalence of substance 
use was obtained. Among participants, 12.7% demonstrated moderate risk to alcohol 
use while 2.9% demonstrated high risk to its use. Fifteen percent (15%) demonstrated 
moderate risk to stimulant use while 1.2% demonstrated high risk to its use. Twenty-
eight percent (28.3%) demonstrated moderate risk to opioid analgesic use while 0.6% 
demonstrated high risk to its use. Male gender was associated with a higher risk of 
tobacco use, alcohol use and stimulant use. Female gender was associated with a higher 
risk of sedative use. Only 3(1.7%) of these participants had received previous treatment 
for a substance use disorder.
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INTRODUCTION
The elderly are prone to some con-
ditions which may predispose them to 
misuse of prescription drugs, alcohol and 
psychoactive substances (Kamel & Gam-
mack, 2006; Pateinakis, Amygdalas, Pa-
teinaki, & Pyrpasopoulou, 2013). A sur-
vey among persons 50 years and above 
in the US revealed that in the past year 
about 60% of their respondents had used 
alcohol, 2.6% marijuana and 0.6% cocaine 
(Blazer & Wu, 2009a) In another national 
survey of drug use conducted in the U.S, 
the authors reported a 12 months preva-
lence of 1.4% for non - prescription use 
of prescription pain killers among those 
aged 50 years and above. Among this 
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subset, 1.7% met the criteria for abuse 
while 7.6% were dependent on these 
drugs (Blazer & Wu, 2009b). Further-
more, a review reported that the number 
of elderly seeking treatment for disorders 
related to substance use and misuse of 
prescription medications has increased in 
recent times (Wang & Andrade, 2013).
The burden of disease attributable to 
alcohol among those aged 70 years and 
above was estimated at 3.7% (Rehm, 
Mathers, Popova et al., 2009). This is of 
medical importance because the elderly 
are predisposed to comorbid medical 
conditions, necessitating prescription of 
several medications which may react ad-
versely when used with some of these 
substances (Moore et al., 2006).
The aims of the study were to deter-
mine the prevalence of, and level of risk 
associated with psychoactive substance 
use and misuse of prescribed medica-
tions-, the socio demographic correlates 
of psychoactive substance use and mis-
use of prescribed medications and the 
treatment needs of elderly participants 
attending three primary health care facili-
ties in Benin-City, Edo state, Nigeria.
METHOD
Setting and population
This is part of a larger study which 
aimed to ascertain the prevalence of psy-
choactive substance use and the level of 
risk associated with the use of psycho-
active substances among adolescents 
and adult outpatient attendees of three 
primary care facilities in Benin-City, Edo 
state. This study was conducted from Au-
gust 2016- April, 2017.
It was a descriptive cross sectional 
study conducted at three primary health 
care facilities in Benin-City namely: The 
General Practice Clinic (GPC), University 
of Benin Teaching Hospital (UBTH), the 
Medical Clinic (MC), Federal Neuropsy-
chiatric Hospital (FNPH), and the General 
Out-Patient Department (GOPD) of the 
General Hospital, Benin City (GH). 
The GPC unit (UBTH) which has a daily 
turnout of 220 patients, the MC unit of 
the FNPH which attends to about 10-15 
patients per day and the GOPD section of 
the GH which all provide primary care ser-
vices were utilized for the study.
For the purpose of this study, data only 
for those aged 60 years and above were 
analysed.
Eligibility: Patients aged 60years and 
above were recruited into the study. 
Those with severe physical or mental 
illness, too intoxicated or those who have 
severe cognitive impairment that may im-
pede questionnaire administration were 
excluded. 
Participants were recruited at each 
center by systematic random sampling 
method.
Ethical consideration
Ethical approval was obtained from the 
Research and Ethical Committee of the 
Federal Neuropsychiatric Hospital, Benin 
City and the Ethics and Research Commit-
tee, University of Benin Teaching Hospi-
tal, Benin City. Additionally, permission 
was sought from the Director of Hospital 
services before patients were recruited 
from the State General Hospital.
Informed consent (both verbal and 
written) was obtained from participants 
before being recruited. 
Confidentiality was maintained by ob-
taining data anonymously using serial 
numbers which were stored in a place 
inaccessible to those not involved in 
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the study. Participants were informed of 
their right to withdraw from the study at 
any point and that refusal to participate 
would not interfere adversely with their 
treatment. All participants were given 
appropriate intervention during the 
interview.
Measures 
A clinician designed semi structured 
questionnaire to assess socio-demo-
graphic variables of participants and a his-
tory of previous treatment was utilized for 
the study. The variables were age, gender, 
religion, level of education, occupation, 
marital status and a previous treatment 
for substance use. 
Misuse of prescription drug deter-
mined as medications taken for reasons 
other than prescription, or taken them 
more frequently or at higher doses than 
prescribed (WHO ASSIST Working Group, 
2002)
The Alcohol, Smoking, Substance In-
volvement Screening Test (ASSIST)(WHO 
ASSIST Working Group, 2002). 
An interviewer administered question-
naire that screens for all levels of problems 
or risky substance use. It obtains informa-
tion about lifetime use of substances and 
use of substance with associated prob-
lems in the last three months. A risk score 
is provided for each substance and scores 
are grouped into low, moderate or high 
risk. A score of 0-3 depicts low risk for all 
substances except alcohol where a score 
of 0-10 depicts low risk and requires no 
intervention. A score of 4-26 depicts mod-
erate risk with the exception of alcohol in 
which a score of 11-26 depicts moderate 
risk, requiring brief intervention. For all 
substances, a score greater than 26 shows 
high risk which requires intensive treat-
ment according to the ASSIST algorithm. 
Moderate risk scores depict harmful or 
hazardous use while high risk scores sug-
gest a risk of dependence. This instrument 
has undergone testing in three phases to 
ensure feasibility, validity and reliability. 
Internal consistency (Cronbach’s α) was 
above 0.80 for most domains of the AS-
SIST. Similarly, the ASSIST demonstrated 
good concurrent, construct and divergent 
validity with similar instruments (Humen-
iuk & Ali, 2006; Humeniuk et al., 2008) 
A pilot study was conducted prior to the 
main study. The participants employed in 
the pilot study were excluded from the 
main study. The results showed that the 
questionnaire was easy to administer and 
adaptable to the participants. An average 
administration time of about 10 minutes 
was observed for each interview which 
made its administration acceptable to the 
participants.
Procedure
Two research assistants trained on the 
administration of the ASSIST by Ayodele 
Fela-Thomas (A.F.T) administered ques-
tionnaire. Inter rater reliability was good 
with a value of 0.7 for (Cohen’s kappa). 
Eligible participants were selected using 
systematic random sampling technique 
at the general outpatient hall while wait-
ing to see the doctor. Interview was con-
ducted in a secluded room within the out-
patient clinic for privacy. All participants 
were given the appropriate treatment 
after discussing their scores with them 
at point of data collection. The attending 
physician was also informed of those who 
needed referral for intensive treatment.
Data analysis
Analysis was done using the Statisti-
cal Package for Social Sciences (SPSS) ver-
sion 20. To explore the data, descriptive 
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statistics (frequency, mean, standard de-
viation) was utilized. Categorized ASSIST 
scores were used to categorize the level of 
risk and cross tabulated with the socio-de-
mographic variables for chi square test of 
association. Fisher’s exact test/ Bonferroni 
correction was implemented where appro-
priate. A significance level of <0.05 was set.
RESULTS
A total of 173 participants aged 60 
years and above were recruited from the 
three primary care facilities. The socio-
demographic variables of the participants 
are as shown in Table 1. Only 3 (1.7%) had 
received previous treatment for a sub-
stance use disorder.
Prevalence of Substance Use
Lifetime use
The most common ever used substance 
by these elderly participants was alcohol, 
with a lifetime prevalence of 70.5%. The 
least ever used substance was marijuana 
with a lifetime prevalence of 1.2%. (See 
Table 2.)
Current Use
The most commonly used psychoactive 
substance in the past three months by the 
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Table 1. Socio-demographic and clinical characteristics of participants



























participants was opioid analgesics, with a 
point prevalence of 34.7%. The least used 
substance currently was marijuana with a 
prevalence of 0.6%. (See Table 2.)
Use in past three months
Among participants, 8(4.6%) used to-
bacco weekly (1-4 times per week) or dai-
ly while 24(13.9%) drank alcohol weekly 
or daily in the last three months. Similarly, 
21(12.1%) of the participants used opioid 
pain medications weekly or daily in the 
past three months while 14(8.1%) used 
stimulants weekly or daily in the past 
three months. (Table not shown.)
Level of risk and treatment needs
Of the 173 elderly participants, 2.9% 
(n=5) demonstrated high risk of alcohol 
use requiring intensive treatment while 
12.7% (n=22) demonstrated moderate 
risk (hazardous use) to alcohol use re-
quiring brief intervention. Two (1.2%) 
demonstrated a high risk of use to stimu-
lants, requiring more intensive treatment 
while 15.0% (n=26) were observed to 
be at moderate risk (hazardous use) of 
stimulant use, requiring brief interven-
tion. One (0.6%) demonstrated high risk 
to tobacco and opioid pain medication 
use respectively thus requiring intensive 
treatment. (See Table 3).
Socio-demographics and level of risk
Males demonstrated a higher risk to to-
bacco use (p<0.001), alcohol use (p<0.001) 
and stimulant use (p=0.014) compared to 
the females. Those with secondary level 
of education were more likely to have a 
high risk of tobacco use (p=0.011) and 
alcohol use (7.1%, p=0.004) compared to 
those with other levels of education.
A high risk of sedative use was associ-
ated with the female gender (p=0.020). 
(Table not shown).
Pattern of use and level of risk
Alcohol
All five participants whom demonstrat-
ed high risk to alcohol use had taken alco-
hol weekly (1-4 times per week) or daily 
in the past three months while 8 (36.4%) 
out of the 22 participants with moderate 
risk of alcohol use had consumed alcohol 
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Table 2. Lifetime and current psychoactive substance use
Lifetime use Current use
Variables (N=173) YES NO YES NO
n % n % n % n %
Tobacco 59 34.1 114 65.9 13 7.5 160 92.5
Alcohol 122 70.5 51 29.5 59 34.1 113 65.3
Marijuana 2 1.2 171 98.8 1 0.6 172 99.4
Cocaine - - 173 100 - - 173 100
Stimulant 77 44.5 96 55.5 39 22.5 134 77.5
Inhalant - - 173 100 - - 173 100
Sedatives 28 16.2 145 83.8 18 10.4 155 89.6
Hallucinogens - - 173 100 - - 173 100
Heroine 73 42.2 100 57.8 60 34.7 113 65.3
Others - 173 100 - - 173 100
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weekly or daily in the past three months 
(p=0.016). Similarly, all two participants 
(14.3%) who were observed to be at high 
risk of stimulant use consumed stimu-
lants daily or weekly (1-4 times per week) 
in the past three months. (See Table 3).
DISCUSSION
The most commonly ever used psy-
choactive substances among the elderly 
participants in descending order were 
alcohol, stimulant (kolanut), opioid pain 
medications, tobacco, sedatives and 
marijuana. The most commonly used psy-
choactive substances in the past three 
months in descending order were opioid 
pain medications, alcohol, stimulants, 
sedatives, tobacco and marijuana. None 
of the participants reported the use of 
cocaine, inhalants and hallucinogens. 
Among participants, 2.9% demonstrated 
high risk for alcohol use while 12.7% dem-
onstrated moderate risk for its use. High 
risk for stimulant use was demonstrated 
by 1.2% while 15% demonstrated moder-
ate risk for its use. Similarly, 0.6% demon-
strated high risk for opioid analgesic use 
while 28.3% demonstrated moderate risk 
for its use. Regarding tobacco use, 0.6% of 
the participants demonstrated high risk 
while 9.2% demonstrated moderate risk 
for its use. 
We observed that opioid analgesics and 
the use of sedatives was common among 
the participants, with a current prevalence 
of 34.7% and 10.4% respectively. This re-
sult is in line with the results reported in 
an epidemiological survey on the preva-
lence of benzodiazepine use conducted 
among those aged 65 years and older in 
Quebec, Canada (Voyer, Préville, Cohen, 
Berbiche, & Béland, 2010); however, dif-
fers from the findings of other studies, 
where lower prevalence rates of pre-
scription pain medications were reported 
(Blazer & Wu, 2009b; Moore et al., 2009). 
The dissimilarity in findings may be due to 
methodological differences. For instance, 
the two studies were community surveys, 
whereas, ours was a sample of hospital 
outpatients that are more likely to have 
been prescribed medications at some 
time, or present with problems that may 
predispose them to abuse these medi-
cations (Boudreau et al., 2009; Simoni-
Wastila & Yang, 2006). Again, methods 
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Table 3. Level of risk of psychoactive substance use (substance use related harm)
Variable (N=173)
Low risk Moderate risk High risk
N % n % N %
Tobacco 156 90.2 16 9.2 1 0.6
Alcohol 146 84.4 22 12.7 5 2.9
Marijuana 171 98.8 2 1.2 - -
Cocaine 173 100.0 - - - -
Stimulants 145 83.8 26 15.0 2 1.2%
Inhalant 173 100 - - - -
Sedative 162 93.6 11 6.4 - -
Hallucinogen 173 100 - - - -
Heroine/opioid pain medication 123 71.1 49 28.3 1 0.6
Others 173 100 - - - -
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of assessment of outcomes of the studies 
differ, thus the findings may not be com-
parable. 
We also reported that alcohol and to-
bacco use was common with a current 
prevalence of 34.1% and 7.5% respective-
ly among participants. These values are 
quite smaller than the values reported in 
one study in which they found a preva-
lence of 45% and 14% respectively for 
both alcohol and tobacco use among their 
community based respondents (Moore 
et al., 2009). A plausible explanation for 
this discrepancy in findings may be due to 
the diagnostic criteria used in both stud-
ies. For instance, current prevalence was 
assessed in the past three months in this 
study as compared to the referenced one 
which was assessed in the last 12 months.
The wide acceptability of alcohol and 
the perceived health benefits albeit er-
roneously associated with its use may 
account for its common use among this 
cohort (Fillmore, Stockwell, Chikritzhs, 
Bostrom, & Kerr, 2007; Schmidt, Mäkelä, 
Rehm, & Room, 2010). 
We observed that a significant number 
of these elderly participants exhibited 
hazardous use of alcohol (12.7%) and a 
smaller number were seen to be at a high 
risk of dependence (2.9%). These findings 
are comparable to the results obtained 
from other studies (Blazer & Wu, 2011; 
Reid, Fiellin, & O’connor, 1999). Some fac-
tors associated with the ageing process 
have been reported as risks for problem-
atic drinking in later life (Dar, 2006). This 
is of significant health implication be-
cause of the effects of alcohol on the age-
ing body. In the elderly, alcohol reaches 
higher blood levels due to a decrease in 
body water and mass. Moreover, the rate 
of metabolism for alcohol is also reduced 
with age. Therefore, it accumulates in the 
body leading to intoxication even with 
lower amounts of intake (Caputo et al., 
2012).
Male gender was significantly associ-
ated with the risk of alcohol, tobacco and 
stimulant use, a finding similar to reports 
from other studies (Teixidó-Compañó et 
al., 2018; Wilsnack, Wilsnack, Kristjanson, 
Vogeltanz-Holm, & Gmel, 2009). 
It has been postulated that an inter-
action between biological, environmen-
tal and psychosocial factors may explain 
the preponderance of males indulging in 
psychoactive substance use as compared 
to females (Becker, McClellan, & Reed, 
2017). Moreover, the physiological re-
sponse of the female body to these sub-
stances, the clinical harm attributable to 
these drugs in females as compared to 
males and low societal tolerance for their 
use among the female gender may well 
explain their low level of use of psychoac-
tive substances (Tuchman, 2010).
We reported that female gender was 
associated with a risk of sedative use, a 
result similar to that reported by other 
studies (Olfson, King, & Schoenbaum, 
2015; Teixidó-Compañó et al., 2018). 
However, is in dissonance with the results 
obtained from a study among elderly pa-
tients in San Francisco. Contrary to our 
finding, their results showed that 16% of 
men and 9% of women reported misuse 
of sedatives in the last 30 days and female 
gender was not predictive of a risk of sed-
ative misuse (Satre, Sterling, Mackin, & 
Weisner, 2011).
Regarding the association between fe-
male gender and increased risk of seda-
tive use, this may be explained by the fact 
that females are more likely to present 
at health facilities with chronic medical 
conditions or other medical complaints 
which may in ardvertently affect sleep, 
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thus they are more likely to be prescribed 
these medications which may predis-
pose them to the risk of misuse of such 
medications(Linnet et al., 2016).
Even though, a large number of the 
participants demonstrated low risk to 
most psychoactive substance use, a sub-
stantial number demonstrated hazardous 
and high risk use to some psychoactive 
substances. For instance, all five partici-
pants who demonstrated high risk to al-
cohol use consumed alcohol weekly or 
daily in the past three months, yet only 
1.7% of the total participants had re-
ceived treatment for their use of psycho-
active substances prior to this study. This 
is similar to the findings of Compton et 
al, in a survey of drug abuse in the U.S. 
They noted that those seeking treatment 
for substance use disorder was still low 
(Compton, Thomas, Stinson, & Grant, 
2007).
Currently, treatment provisions for 
substance use disorders in the elderly 
are scarce and few. Asides this, most 
treatment strategies are designed to 
cater for the younger ones with little 
or no provision for the elderly patients 
with psychoactive substance use disor-
ders (Schultz, Arndt, & Liesveld, 2003). 
This is quite important for policy formu-
lation as these individuals even though 
detected may not receive any interven-
tion due to constraints associated with 
referrals to a specialized treatment fa-
cility. More so, that the effects of these 
substances are particularly detrimental 
in the elderly. 
Limitations and strengths
The study had several limitations and 
some strengths. In terms of limitations, 
the sample size was small and it was of a 
cross sectional design. Also, the subjective 
method (self-report) of assessing psycho-
active substance use may not represent 
the true extent of use by these elderly 
participants due to social desirability 
bias or minimization. There is also a lack 
of validation of the ASSIST questionnaire 
among the elderly population.
In terms of strengths, to the best of our 
knowledge, there exists no current study 
on psychoactive substance use and its risk 
of use among the elderly in the Nigerian 
environment. Also being a multicenter 
study, the results can be generalized.
CONCLUSION
We reported alcohol as the most com-
monly ever used substance among this 
cohort. The least used substance was 
marijuana. The most currently used sub-
stance was opioid analgesics. Among par-
ticipants, 2.9% demonstrated high risk for 
alcohol use, 1.2% demonstrated high risk 
for stimulant use while 0.6% demonstrat-
ed high risk for opioids use.
Male gender was significantly associ-
ated with a higher risk of tobacco, alcohol 
and stimulant use. Female gender was 
associated with a higher risk of sedative 
use. Only 3(1.7%) of these participants 
had received previous treatment for a 
substance use disorder in the past.
Clinicians should routinely assess the 
elderly for psychoactive substance use, 
and adequate intervention given to those 
diagnosed with psychoactive substance 
use disorder. Health institutions, Men-
tal health and Addiction therapy policy 
makers should consider making national 
policies for treatment of elderly persons 
with psychoactive substance disorders for 
a healthier life. Future studies with larger 
sample sizes are recommended.
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